Cannabis-associated psychosis: Neural substrate and clinical impact
The DOI matches its Crossref record; 65 of the 65 references it cites were found in a registry or an index.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Biological insights from 108 schizophrenia-associated genetic loci
Schizophrenia Working Group of the Psychiatric Genomics Consortium (2014) · Nature · doi:10.1038/nature13595 · Cited by 7,577
The basis of anisotropic water diffusion in the nervous system—A technical review.
Beaulieu, C. (2002) · NMR in Biomedicine · doi:10.1002/nbm.782 · Cited by 4,628 · cited 2×
“Diffusion tensor imaging (DTI) provides an indication of the integrity of whitematter tracts (Beaulieu, 2002).”
Kapur, S. (2003) · American Journal of Psychiatry · doi:10.1176/appi.ajp.160.1.13 · Cited by 2,813 · cited 2×
“The attribution of salience is altered in psychosis (Kapur, 2003), and this accompanied by altered activation in the striatum (Diaconescu et al., 2011; Jensen et al., 2008; Roiser et al., 2012).”
Neurocognitive deficit in schizophrenia: A quantitative review of the evidence.
Heinrichs, R. W., & Zakzanis, K. K. (1998) · Neuropsychology · doi:10.1037/0894-4105.12.3.426 · Cited by 2,798
Misunderstanding analysis of covariance.
Miller, G. A., & Chapman, J. P. (2001) · Journal of Abnormal Psychology · doi:10.1037/0021-843x.110.1.40 · Cited by 2,136 · cited 1×
“Simply covarying for alcohol use can lead to spurious results (Miller and Chapman, 2001; Weiland et al., 2015).”
Caspi, A., Moffitt, T. E., Cannon, M., McClay, J., Murray, R., Harrington, H., Taylor, A., Arseneault, L., Williams, B., Braithwaite, A., et al. (2005) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.01.026 · Cited by 1,409
Self-citationCannabis use in adolescence and risk for adult psychosis: longitudinal prospective study.
Arseneault, L., Cannon, M., Poulton, R., Murray, R., Caspi, A., & Moffitt, T. E. (2002) · BMJ · doi:10.1136/bmj.325.7374.1212 · Cited by 1,399 · cited 6×
“…of cannabis use In the Dunedin cohort study, those who started to use cannabis at age 18 or later showed only a small, non-significant increase in the risk of schizophrenia-like psychosis by age 26, but the risk increased fourfold among those starting at age 15 or earlier (Arseneault et al., 2002).”
InfluentialSelf-citationA Comprehensive Profile of Brain Enzymes that Hydrolyze the Endocannabinoid 2-Arachidonoylglycerol
Blankman, J. L., Simon, G. M., & Cravatt, B. F. (2007) · Chemistry & Biology · doi:10.1016/j.chembiol.2007.11.006 · Cited by 1,177
Akbarian, S. (1995) · Archives of General Psychiatry · doi:10.1001/archpsyc.1995.03950160008002 · Cited by 1,002
Meta-analysis of the Association Between the Level of Cannabis Use and Risk of Psychosis
Marconi, A., Di Forti, M., Lewis, C. M., Murray, R. M., & Vassos, E. (2016) · Schizophrenia Bulletin · doi:10.1093/schbul/sbw003 · Cited by 899
Self-citationZammit, S., Allebeck, P., Andreasson, S., Lundberg, I., & Lewis, G. (2002) · BMJ · doi:10.1136/bmj.325.7374.1199 · Cited by 871
Effects of Cannabis Use on Human Behavior, Including Cognition, Motivation, and Psychosis: A Review
Volkow, N. D., Swanson, J. M., Evins, A. E., DeLisi, L. E., Meier, M. H., Gonzalez, R., Bloomfield, M. A. P., Curran, H. V., & Baler, R. (2016) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2015.3278 · Cited by 867
Henquet, C., Krabbendam, L., Spauwen, J., Kaplan, C., Lieb, R., Wittchen, H.-U., & van Os, J. (2005) · BMJ · doi:10.1136/bmj.38267.664086.63 · Cited by 765
Elevated Striatal Dopamine Function Linked to Prodromal Signs of Schizophrenia
Howes, O. D., Montgomery, A. J., Asselin, M.-C., Murray, R. M., Valli, I., Tabraham, P., Bramon-Bosch, E., Valmaggia, L., Johns, L., Broome, M., et al. (2009) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2008.514 · Cited by 744 · cited 3×
“Furthermore, excess dopamine release in the associative striatum predicts conversion from a prodromal state to frank psychosis (Howes et al., 2009) and relates to the magnitude of psychotic symptoms (Howes et al., 2009; Thompson et al., 2013).”
InfluentialSelf-citationVolk, D. W., Austin, M. C., Pierri, J. N., Sampson, A. R., & Lewis, D. A. (2000) · Archives of General Psychiatry · doi:10.1001/archpsyc.57.3.237 · Cited by 697
Self-citationBhattacharyya, S., Morrison, P. D., Fusar-Poli, P., Martin-Santos, R., Borgwardt, S., Winton-Brown, T., Nosarti, C., O' Carroll, C. M., Seal, M., Allen, P., et al. (2010) · Neuropsychopharmacology · doi:10.1038/npp.2009.184 · Cited by 680
Self-citationGamma frequency-range abnormalities to auditory stimulation in schizophrenia
Kwon, J. S., O'Donnell, B. F., Wallenstein, G. V., Greene, R. W., Hirayasu, Y., Nestor, P. G., Hasselmo, M. E., Potts, G. F., Shenton, M. E., & McCarley, R. W. (1999) · Archives of General Psychiatry · doi:10.1001/archpsyc.56.11.1001 · Cited by 654 · cited 1×
“Patients with psychotic disorder show attenuated g-band (~40 Hz) responses (Krishnan et al., 2009; Kwon et al., 1999; Light et al., 2006; Spencer et al., 2008).”
Multiple Functions of Endocannabinoid Signaling in the Brain
Katona, I., & Freund, T. F. (2012) · Annual Review of Neuroscience · doi:10.1146/annurev-neuro-062111-150420 · Cited by 630 · cited 4×
“Anandamide, a partial cannabinoid 1 receptor (CB1R) agonist, shows relatively low concentrations in brain (Katona and Freund, 2012; Pertwee et al., 2010), whereas 2-AG, a full CB1R agonist, is present at much higher concentrations (Stella et al., 1997).”
InfluentialD’Souza, D. C., Abi-Saab, W. M., Madonick, S., Forselius-Bielen, K., Doersch, A., Braley, G., Gueorguieva, R., Cooper, T. B., & Krystal, J. H. (2005) · Biological Psychiatry · doi:10.1016/j.biopsych.2004.12.006 · Cited by 617 · cited 5×
“The study failed to observe any “beneficial” effects of cannabinoid agonists in individuals with schizophrenia e challenging the cannabis selfmedication hypothesis in schizophrenia (D'Souza et al., 2005).”
InfluentialSelf-citationHirvonen, J., Goodwin, R. S., Li, C.-T., Terry, G. E., Zoghbi, S. S., Morse, C., Pike, V. W., Volkow, N. D., Huestis, M. A., & Innis, R. B. (2012) · Molecular Psychiatry · doi:10.1038/mp.2011.82 · Cited by 587 · cited 2×
“Cannabinoids produce acute transient dose-related deficits in memory, executive function, abstract ability, decision making, and attention (Hart et al., 2001; Heishman et al., 1990; Hooker and Jones, 1987; Leweke et al., 1998; Marks and MacAvoy, 1989; Miller et al., 1977; Ranganathan et al., 2006).”
Meta-analysis of the P300 and P50 waveforms in schizophrenia
BRAMON, E. (2004) · Schizophrenia Research · doi:10.1016/j.schres.2004.01.004 · Cited by 569
High-potency cannabis and the risk of psychosis
Di Forti, M., Morgan, C., Dazzan, P., Pariante, C., Mondelli, V., Marques, T. R., Handley, R., Luzi, S., Russo, M., Paparelli, A., et al. (2009) · British Journal of Psychiatry · doi:10.1192/bjp.bp.109.064220 · Cited by 567 · cited 1×
“However, a number of studies have addressed this issue and not found the effects sufficient to negate the effects of cannabis (e.g. Arseneault et al., 2002), even when use of tobacco was accounted for (Di Forti et al., 2009, 2015).”
Self-citationGulyas, A. I., Cravatt, B. F., Bracey, M. H., Dinh, T. P., Piomelli, D., Boscia, F., & Freund, T. F. (2004) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2004.03428.x · Cited by 561
Di Forti, M., Sallis, H., Allegri, F., Trotta, A., Ferraro, L., Stilo, S. A., Marconi, A., La Cascia, C., Reis Marques, T., Pariante, C., et al. (2014) · Schizophrenia Bulletin · doi:10.1093/schbul/sbt181 · Cited by 470
Self-citationFusar-Poli, P., Crippa, J. A., Bhattacharyya, S., Borgwardt, S. J., Allen, P., Martin-Santos, R., Seal, M., Surguladze, S. A., O’Carrol, C., Atakan, Z., et al. (2009) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2008.519 · Cited by 465
Self-citationCannabis dependence and psychotic symptoms in young people
FERGUSSON, D. M., HORWOOD, L. J., & SWAIN-CAMPBELL, N. R. (2003) · Psychological Medicine · doi:10.1017/s0033291702006402 · Cited by 415 · cited 3×
“A study from Christchurch showed that once psychotic symptoms developed, people tended to smoke less cannabis (Fergusson et al., 2003, 2015).”
Association Between Cannabis and Psychosis: Epidemiologic Evidence
Gage, S. H., Hickman, M., & Zammit, S. (2016) · Biological Psychiatry · doi:10.1016/j.biopsych.2015.08.001 · Cited by 379
Decreased Volume of the Brain Reward System in Alcoholism
Makris, N., Oscar-Berman, M., Jaffin, S. K., Hodge, S. M., Kennedy, D. N., Caviness, V. S., Marinkovic, K., Breiter, H. C., Gasic, G. P., & Harris, G. J. (2008) · Biological Psychiatry · doi:10.1016/j.biopsych.2008.01.018 · Cited by 372 · cited 2×
“, 1994), and alcohol use is robustly associated with reduced grey matter volumes (Fein et al., 2002; Jernigan et al., 1991; Makris et al., 2008; Paul et al., 2008).”
Cannabinoids Enhance Subsecond Dopamine Release in the Nucleus Accumbens of Awake Rats
Cheer, J. F., Wassum, K. M., Heien, M. L. A. V., Phillips, P. E. M., & Wightman, R. M. (2004) · The Journal of Neuroscience · doi:10.1523/jneurosci.0529-04.2004 · Cited by 343
Schoeler, T., Monk, A., Sami, M. B., Klamerus, E., Foglia, E., Brown, R., Camuri, G., Altamura, A. C., Murray, R., & Bhattacharyya, S. (2016) · The Lancet Psychiatry · doi:10.1016/s2215-0366(15)00363-6 · Cited by 322 · cited 2×
“However, a recent meta-analysis reported modest non-acute impairments across a number of memory domains, particularly prospective and verbal memory (Schoeler et al., 2016).”
Self-citationEffects of cannabidiol (CBD) on regional cerebral blood flow
Crippa, J. A. D. S., Zuardi, A. W., Garrido, G. E. J., Wichert-Ana, L., Guarnieri, R., Ferrari, L., Azevedo-Marques, P. M., Hallak, J. E. C., McGuire, P. K., & Busatto, G. F. (2004) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300340 · Cited by 307
Self-citationEffects of cannabidiol on schizophrenia-like symptoms in people who use cannabis
Morgan, C. J. A., & Curran, H. V. (2008) · British Journal of Psychiatry · doi:10.1192/bjp.bp.107.046649 · Cited by 300 · cited 1×
“A study testing hair for cannabinoids, showed that users with both detectable THC and CBD had fewer psychotic symptoms than those in whom only THC could be detected (Morgan and Curran, 2008).”
Cousijn, J., Wiers, R. W., Ridderinkhof, K. R., van den Brink, W., Veltman, D. J., & Goudriaan, A. E. (2012) · NeuroImage · doi:10.1016/j.neuroimage.2011.09.046 · Cited by 287
Curley, A. A., Arion, D., Volk, D. W., Asafu-Adjei, J. K., Sampson, A. R., Fish, K. N., & Lewis, D. A. (2011) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2011.11010052 · Cited by 283 · cited 2×
“In addition, lower mRNA and protein expression of the GABA synthesizing enzyme GAD67, one of the most consistently reported findings in postmortem studies of schizophrenia (Akbarian et al., 1995; Curley et al., 2011; Duncan et al., 2010; Guidotti et al., 2000; Straub et al., 2007; Volk et al., 2000), could lead to def…”
Self-citationMarijuana Intoxication : Common Experiences
TART, C. T. (1970) · Nature · doi:10.1038/226701a0 · Cited by 252
Cannabinoid Modulation of Amygdala Reactivity to Social Signals of Threat in Humans
Phan, K. L., Angstadt, M., Golden, J., Onyewuenyi, I., Popovska, A., & de Wit, H. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.5603-07.2008 · Cited by 251
Long-term effects of marijuana use on the brain
Filbey, F. M., Aslan, S., Calhoun, V. D., Spence, J. S., Damaraju, E., Caprihan, A., & Segall, J. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1415297111 · Cited by 249 · cited 1×
“…depersonalization and derealization, distorted sensory perceptions, and extreme slowing of time (Bhattacharyya et al., 2010a, 2012a, 2015a; D'Souza et al., 2004, 2008a,b, 2012; Freeman et al., 2015; Koethe et al., 2006; Leweke et al., 1999a,b; Leweke et al., 2000; Morrison et al., 2009b).”
Wiles, N. J., Zammit, S., Bebbington, P., Singleton, N., Meltzer, H., & Lewis, G. (2006) · British Journal of Psychiatry · doi:10.1192/bjp.bp.105.012179 · Cited by 245 · cited 1×
“Consistent with studies in rodents and non-human primates (reviewed in Lichtman et al., 2002; Wilson and Nicoll, 2002), the most robust effects of cannabinoids in humans target memory and attention (Hart et al., 2001; Heishman et al., 1990; Hooker and Jones, 1987; M. Leweke et al., 1998; Marks and…”
Confirmation that the AKT1 (rs2494732) genotype influences the risk of psychosis in cannabis users
Di Forti, M., Iyegbe, C., Sallis, H., Kolliakou, A., Falcone, M. A., Paparelli, A., Sirianni, M., La Cascia, C., Stilo, S. A., Marques, T. R., et al. (2012) · Biological Psychiatry · doi:10.1016/j.biopsych.2012.06.020 · Cited by 234
Self-citationThe formation of abnormal associations in schizophrenia: Neural and behavioral evidence
Jensen, J., Willeit, M., Zipursky, R. B., Savina, I., Smith, A. J., Menon, M., Crawley, A. P., & Kapur, S. (2008) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301437 · Cited by 225 · cited 1×
“The attribution of salience is altered in psychosis (Kapur, 2003), and this accompanied by altered activation in the striatum (Diaconescu et al., 2011; Jensen et al., 2008; Roiser et al., 2012).”
Cannabis use predicts future psychotic symptoms, and vice versa
Ferdinand, R. F., Sondeijker, F., Van Der Ende, J., Selten, J., Huizink, A., & Verhulst, F. C. (2005) · Addiction · doi:10.1111/j.1360-0443.2005.01070.x · Cited by 212 · cited 2×
“Ten found that cannabis usewas associated with a significantly increased risk of the subsequent development of psychotic symptoms or psychotic illness (Arseneault et al., 2002; van Os et al., 2002; Weiser et al., 2002; Zammit et al., 2002; Fergusson et al., 2003; Ferdinand et al., 2005; Henquet et al., 2005; Manrique-…”
Neural and Behavioral Correlates of Aberrant Salience in Individuals at Risk for Psychosis
Roiser, J. P., Howes, O. D., Chaddock, C. A., Joyce, E. M., & McGuire, P. (2013) · Schizophrenia Bulletin · doi:10.1093/schbul/sbs147 · Cited by 205
Self-citationBhattacharyya, S. (2012) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2011.161 · Cited by 203 · cited 2×
“The effect of THC on caudate activation was inversely related to the severity of psychotic symptoms it induced (Bhattacharyya et al., 2012a,b).”
Genetic predisposition to schizophrenia associated with increased use of cannabis
Power, R. A., Verweij, K. J. H., Zuhair, M., Montgomery, G. W., Henders, A. K., Heath, A. C., Madden, P. A. F., Medland, S. E., Wray, N. R., & Martin, N. G. (2014) · Molecular Psychiatry · doi:10.1038/mp.2014.51 · Cited by 196
Sensory-Evoked Gamma Oscillations in Chronic Schizophrenia
Spencer, K. M., Niznikiewicz, M. A., Shenton, M. E., & McCarley, R. W. (2008) · Biological Psychiatry · doi:10.1016/j.biopsych.2007.10.017 · Cited by 182
Worth the wait: effects of age of onset of marijuana use on white matter and impulsivity
Gruber, S. A., Dahlgren, M. K., Sagar, K. A., Gönenç, A., & Lukas, S. E. (2014) · Psychopharmacology · doi:10.1007/s00213-013-3326-z · Cited by 177
Epidemiological analysis of alcohol and drug use as risk factors for psychotic experiences
TIEN, A. Y., & ANTHONY, J. C. (1990) · The Journal of Nervous and Mental Disease · doi:10.1097/00005053-199008000-00001 · Cited by 175
Duncan, C. E., Webster, M. J., Rothmond, D. A., Bahn, S., Elashoff, M., & Shannon Weickert, C. (2010) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2009.12.007 · Cited by 169 · cited 2×
“In addition, lower mRNA and protein expression of the GABA synthesizing enzyme GAD67, one of the most consistently reported findings in postmortem studies of schizophrenia (Akbarian et al., 1995; Curley et al., 2011; Duncan et al., 2010; Guidotti et al., 2000; Straub et al., 2007; Volk et al., 2000), could lead to def…”
Fusar-Poli, P., Allen, P., Bhattacharyya, S., Crippa, J. A., Mechelli, A., Borgwardt, S., Martin-Santos, R., Seal, M. L., O'Carrol, C., Atakan, Z., et al. (2010) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145709990617 · Cited by 163 · cited 2×
“In addition, CBD (but not THC) reduced effective connectivity between the cingulate and amygdala during processing of fearful faces (Fusar-Poli et al., 2010).”
Self-citationDemirakca, T., Sartorius, A., Ende, G., Meyer, N., Welzel, H., Skopp, G., Mann, K., & Hermann, D. (2010) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2010.09.020 · Cited by 162 · cited 3×
“(Demirakca et al., 2011) 2011 11 (22y) 13 (23y) CU: age first use ¼ 17, frequency ¼ 25 days past month, 300 days past year.”
Altered Frontal Cortical Volume and Decision Making in Adolescent Cannabis Users
Churchwell, J. C., Lopez-Larson, M., & Yurgelun-Todd, D. A. (2010) · Frontiers in Psychology · doi:10.3389/fpsyg.2010.00225 · Cited by 159
Winton-Brown, T. T., Allen, P., Bhattacharrya, S., Borgwardt, S. J., Fusar-Poli, P., Crippa, J. A., Seal, M. L., Martin-Santos, R., Ffytche, D., Zuardi, A. W., et al. (2011) · Neuropsychopharmacology · doi:10.1038/npp.2011.17 · Cited by 146
Potential Reporting Bias in fMRI Studies of the Brain
David, S. P., Ware, J. J., Chu, I. M., Loftus, P. D., Fusar-Poli, P., Radua, J., Munafò, M. R., & Ioannidis, J. P. A. (2013) · PLoS ONE · doi:10.1371/journal.pone.0070104 · Cited by 130
Impact of Cannabis Use on Brain Function in Adolescents
JACOBSEN, L. K., MENCL, W. E., WESTERVELD, M., & PUGH, K. R. (2004) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1308.053 · Cited by 128
Polygenic risk scores for schizophrenia and bipolar disorder associate with addiction
Reginsson, G. W., Ingason, A., Euesden, J., Bjornsdottir, G., Olafsson, S., Sigurdsson, E., Oskarsson, H., Tyrfingsson, T., Runarsdottir, V., Hansdottir, I., et al. (2018) · Addiction Biology · doi:10.1111/adb.12496 · Cited by 112 · cited 1×
“An Icelandic study examined the relationship between the PRS-SCZ and a range of addictive disorders (Reginsson et al., 2017).”
Leweke, F. M., Schneider, U., Thies, M., Münte, T. F., & Emrich, H. M. (1999) · Psychopharmacology · doi:10.1007/s002130050884 · Cited by 102 · cited 2×
“However, CSF studies have not detected quantifiable levels of 2-AG (F. M. Leweke et al., 1999a,b).”
Koethe, D., Gerth, C. W., Neatby, M. A., Haensel, A., Thies, M., Schneider, U., Emrich, H. M., Klosterkötter, J., Schultze-Lutter, F., & Leweke, F. M. (2006) · Schizophrenia Research · doi:10.1016/j.schres.2006.07.023 · Cited by 93 · cited 2×
“clearly confirmed that THC and nabilone can produce transient positive symptoms as well as conceptual disorganization, depersonalization and derealization, distorted sensory perceptions, and extreme slowing of time (Bhattacharyya et al., 2010a, 2012a, 2015a; D'Souza et al., 2004, 2008a,b, 2012; Freeman et al., 2015; K…”
Gage, S. H., Hickman, M., Heron, J., Munafò, M. R., Lewis, G., Macleod, J., & Zammit, S. (2014) · Psychological Medicine · doi:10.1017/s0033291714000531 · Cited by 91
Sevy, S., Smith, G. S., Ma, Y., Dhawan, V., Chaly, T., Kingsley, P. B., Kumra, S., Abdelmessih, S., & Eidelberg, D. (2008) · Psychopharmacology · doi:10.1007/s00213-008-1075-1 · Cited by 83
Shared Predisposition in the Association Between Cannabis Use and Subcortical Brain Structure
Pagliaccio, D., Barch, D. M., Bogdan, R., Wood, P. K., Lynskey, M. T., Heath, A. C., & Agrawal, A. (2015) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2015.1054 · Cited by 77
BOYDELL, J., VAN OS, J., CASPI, A., KENNEDY, N., GIOUROUKOU, E., FEARON, P., FARRELL, M., & MURRAY, R. M. (2006) · Psychological Medicine · doi:10.1017/s0033291706008440 · Cited by 70
Self-citationLinking substance use with symptoms of subclinical psychosis in a community cohort over 30 years
Rössler, W., Hengartner, M. P., Angst, J., & Ajdacic‐Gross, V. (2012) · Addiction · doi:10.1111/j.1360-0443.2011.03760.x · Cited by 67
Shollenbarger, S. G., Price, J., Wieser, J., & Lisdahl, K. (2015) · NeuroImage: Clinical · doi:10.1016/j.nicl.2015.03.024 · Cited by 64
Jansma, J. M., van Hell, H. H., Vanderschuren, L. J. M. J., Bossong, M. G., Jager, G., Kahn, R. S., & Ramsey, N. F. (2013) · Translational Psychiatry · doi:10.1038/tp.2013.6 · Cited by 58 · cited 1×
“(Jansma et al., 2013) THC: 6 mg þ 1 mg (X3) Inh VAS, fMRI (BOLD)”
Aberrant effective connectivity in schizophrenia patients during appetitive conditioning
Diaconescu, A. O., Jensen, J., Wang, H., Willeit, M., Menon, M., Kapur, S., & McIntosh, A. R. (2011) · Frontiers in Human Neuroscience · doi:10.3389/fnhum.2010.00239 · Cited by 43
Cited by
Di Forti, M., Quattrone, D., Freeman, T. P., Tripoli, G., Gayer-Anderson, C., Quigley, H., Rodriguez, V., Jongsma, H. E., Ferraro, L., La Cascia, C., et al. (2019) · The Lancet Psychiatry · doi:10.1016/s2215-0366(19)30048-3 · Cited by 875
Self-citationCannabis use, cannabis use disorder, and comorbid psychiatric illness: a narrative review
Hasin, D., & Walsh, C. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm10010015 · Cited by 142
“Reviews and meta-analyses of prospective studies show that previous cannabis use predicts treated first-episode psychosis [73,74,79,87].”
BackgroundAdverse effects of heavy cannabis use: Even plants can harm the brain
Sideli, L., Trotta, G., Spinazzola, E., La Cascia, C., & Di Forti, M. (2021) · Pain · doi:10.1097/j.pain.0000000000001963 · Cited by 36
“Cross-sectional and prospective studies demonstrate a causal link between cannabis use and psychotic disorder, with greater risk for cannabis users, compared to nonusers.(73,85,88,89) The most recent meta-analysis reported a pooled odds ratio (OR) 5 3.”
BackgroundInfluential
Metadata
- Authors
- Murray, R. M., Englund, A., Abi-Dargham, A., Lewis, D. A., Di Forti, M., Davies, C., Sherif, M., McGuire, P., & D'Souza, D. C.
- Venue
- Neuropharmacology
- Publisher
- Elsevier BV
- Published
- 2017-09
- Volume
- 124
- Pages
- 89-104
- ISSN
- 0028-3908 (ISSN-L)
- OpenAlex
- W2688630157
- Cited by
- 200
- References
- 65
- FWCI
- 12.75
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.